HRNP/siCDC20
| 【Numbering】BKMC123000 | 【CAS】CAS | ||
| 【Item No.】BKMC123000-2 | 【specification】 | ||
|
|||
Name: HRNP / siCDC20
Composition: a 2-nitroimidazole polypeptide cationic lipid siRNA
Grain size: 30-100nm
Application: Tumor therapy
Storage conditions: -4℃
Other instructions: shelf life of half a year in sealed state [Main advantage] HRNP-mediated targeted delivery of siCDC20 sufficiently silenced the expression of CDC20, showing a strong antitumor effect
Message
Composition: a 2-nitroimidazole polypeptide cationic lipid siRNA
Grain size: 30-100nm
Application: Tumor therapy
Storage conditions: -4℃
Other instructions: shelf life of half a year in sealed state [Main advantage] HRNP-mediated targeted delivery of siCDC20 sufficiently silenced the expression of CDC20, showing a strong antitumor effect
Title:Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
Article link:https://baijiahao.baidu.com/s?id=1712652848026334316&wfr=spider&for=pc| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： 仿生巨噬細(xì)胞膜載CRISPR/Cas9
